Whole genome structure and resistance genes in carbapenemase-producing multidrug resistant ST378 Klebsiella pneumoniae
BMC Microbiology volume 23, Article number: 323 (2023)
Carbapenemase-producing Klebsiella pneumoniae (CPKP) is one of the most dangerous multidrug-resistant (MDR) pathogens in human health due to its widespread circulation in the nosocomial environment. CPKP carried by companion dogs, which are close to human beings, should be considered a common threat to public health. However, CPKP dissemination through companion animals is still under consideration of major diagnosis and surveillance systems.
Two CPKP isolates which were genotyped to harbor bla NDM-5-encoding IncX3 plasmids, were subjected to the whole-genome study. Whole bacterial DNA was isolated, sequenced, and assembled with Oxford Nanopore long reads and corrected with short reads from the Illumina NovaSeq 6000 platform. The whole-genome structure and positions of antimicrobial resistance (AMR) genes were identified and visualized using CGView. Worldwide datasets were downloaded from the NCBI GenBank database for whole-genome comparative analysis. The whole-genome phylogenetic analysis was constructed using the identified whole-chromosome SNP sites from K. pneumoniae HS11286.
As a result of the whole-genome identification, 4 heterogenous plasmids and a single chromosome were identified, each carrying various AMR genes. Multiple novel structures were identified from the AMR genes, coupled with mobile gene elements (MGE). The comparative whole-genome epidemiology revealed that ST378 K. pneumoniae is a novel type of CPKP, carrying a higher prevalence of AMR genes.
The characterized whole-genome analysis of this study shows the emergence of a novel type of CPKP strain carrying various AMR genes with variated genomic structures. The presented data in this study show the necessity to develop additional surveillance programs and control measures for a novel type of CPKP strain.
Klebsiella pneumoniae is one of the most notable pathogens worldwide, causing various infections such as bloodstream infections, urinary tract infections and liver abscesses . Neonatal, elderly and immunocompromised nosocomial patients are particularly vulnerable to these infections , posing a threat to public health in our society. Carbapenem is considered the last resort antibiotic prescribed for infections by K. pneumoniae, but the emergence of carbapenemase-producing K. pneumoniae (CPKP) greatly limits this treatment option in medical situations. Carbapenemase production induces resistance not only against carbapenems but also to more than 2–3 classes of antibiotics , leading to dramatically reduced treatment options and increased mortality, ranging from 18.9% to 48.0% for carbapenem-resistant Enterobacterales (CRE) infections [4,5,6]. As a consequence of the overuse of carbapenems, carbapenemase-producing Enterobacterales (CPE) strains have been disseminated worldwide in modern society .
Enterobacterales strains can acquire resistance against carbapenems via three major mechanisms: the production of enzymes such as carbapenemase, porin loss and overexpression of efflux pumps [8, 9]. Although carbapenemase production is the most powerful mechanism, two other pathways can also provide resistance against carbapenems, either solely or in combination with carbapenemase production [10, 11]. A major concern is the coexistence of multiple resistance mechanisms in a single strain, which could result in synergism and lead to even higher levels of resistance.
A nationwide study conducted in our country  showed that the circulation of CPE in the human nosocomial environment was mostly associated with K. pneumoniae ST11 and ST307. In contrast to the results from human investigations, the first detected animal-derived CPKP in our country was identified as ST378 K. pneumoniae . ST378 K. pneumoniae has never been reported as a CPKP anywhere. In the genomic characterization of ST378 K. pneumoniae conducted in the previous study , the identified information was limited to the bla NDM-5 gene-encoded IncX3 plasmid. However, the isolate was found to have resistance against various classes of antimicrobial agents. Therefore, further genomic analysis was necessary to characterize the ST378 isolates.
In this study, genomic characterization was conducted for the isolates using a whole-genome approach. The genomic analysis was conducted to reveal antimicrobial resistance (AMR) genes from the whole-genome and to identify epidemiologic information for the isolates.
The whole-genome sequencing, de novo assembly and annotation
Two strains of ST378 K. pneumoniae (DMCPKP1 and DMCPKP4), confirmed to contain the bla NDM-5 gene-encoded IncX3 plasmid, were used for the analysis . The bacterial isolates were originated from urine samples of Korean dogs hospitalized in Seoul National University. For genome sequencing, DNA purification was performed using a Wizard Genomic DNA Purification Kit (Promega, Madison, WI) from overnight cultures. Two independent genomic DNA libraries were prepared for both short and long read systems and sequenced using Illumina NovaSeq 6000 (Illumina, San Diego, CA, USA) following a paired-end 2 × 150-bp protocol and Oxford Nanopore (Oxford Nanopore Technologies, Oxford, UK) platforms. Guppy basecaller and barcoder v6.0.7 were used for basecalling and demultiplexing all sequencing runs. Reads were trimmed and filtered for long and high-quality reads using FiltLong v0.2.0 to match the raw data to the appropriate data size for assembly. Filtering of read data to proceed with de novo assembly was conducted using Flye v2.8.3 . Assembly of both Illumina and Oxford Nanopore long reads was performed using the Unicycler v0.4.8 hybrid assembler . Circlator v1.5.5 was used to determine whether the assembly resulted in a circular form or linear form . Polishing work was carried out with Pilon v1.23  for the contigs whose structural shape was identified, and the evaluation of the assembly results was done using BUSCO v4.1.2 . After polishing, structural annotation was performed using Prokka v1.14.6  and functional annotation was performed with DIAMOND v 0.9.30 . Gene Ontology (GO)  annotation was performed based on Blast2GO v4.1.9 .
Identification and visualization of characteristic genes from the whole-genome datasets
Antibiotic resistance genes, virulence genes and plasmid replicons were identified using the ResFinder  and PlasmidFinder  databases available on the Center for Genomic Epidemiology (CGE) server (http://www.genomicepidemiology.org). Mobile gene elements (MGEs) and point mutations were also investigated with MobileElementFinder  and PointFinder . The presence of spacers of CRISPR-Cas systems was identified using CRISPRCasFinder 4.2.20 with default parameters . All detected and identified antimicrobial resistance genes were compared to sequences available from the National Center for Biotechnology Information. The schematic mapping was visualized using CGView .
Bioinformatic analysis of the available whole-genome datasets
For comparative whole genome analysis, 67 K. pneumoniae whole genome datasets described in previous articles were accessed from NCBI GenBank database. Since there were no available ST378 K. pneumoniae whole-genome datasets to compare, worldwide K. pneumoniae datasets were used as reference datasets. The high quality SNP calling, filtering, and site validation were conducted using a web-based tool with default parameters , based on K. pneumoniae HS11286 (Genbank accession no. CP003200.1) as the reference. Maximum likelihood (ML) phylogenetic tree was constructed with 1000 bootstrap values using MEGA-11 software . An antimicrobial resistance gene distribution heatmap was generated using the interactive tree of life (iTOLs) tool. Epidemiological profile was denoted and displayed alongside the phylogenetic tree on the same server. In silico multi-locus sequence typing (MLST) using seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA) was conducted for the strains in this study and all chromosomal datasets downloaded from GenBank, using MLST 2.0  available on the CGE server.
General profiles of the sequenced and assembled whole-genomes of CPKP isolates
As a result of sequencing, high-quality assembled contig records longer than 5,290,663 base pairs were generated, and the total GC content of both strains was about 57%. As a result of the alignment, over 97% of the base reads were successfully mapped. The quality of sequencing and mapped reads was presented in Supplementary Table S1. Each strain was found to carry a single chromosome, and four plasmids were identified from both strains (Table 1). Multiple plasmids were identified from both isolates, featuring various lengths ranging from 46 to 456 kbp.
Characterization of the chromosomes of the CPKP isolates
The chromosome of each CPKP strain consisted of 5.29 MB of genes (Fig. 1). DMCPKP4 had a slightly longer chromosome than DMCPKP1. The chromosomes of DMCPKP1 and DMCPKP4 contained 4,886 and 4,896 CDS encoding sites, respectively. Both isolates were identified to carry bla SHV-119 in their chromosomes. The chromosomes were also found to have various mutated sites that contribute to AMR, including ompK36, ompK37, acrR, gyrA and parC. Genomic sites of ompK35, gyrB, and rpsL were found without mutations.
The ompK36 gene was found to have multiple amino acid substitutions (3 sites of deletion and 17 sites of substitution) from the ompK36 gene of K. pneumoniae isolate 1,537,514 (accessed as GenBank no. KY086540.1). The complete CDS of this gene was matched with 100% identity and query coverage via a BLAST search with the opmK36 gene of K. pneumoniae strain 487,881 (GenBank no. MG576697.1). Moreover, ompK37 was found to have 2-point mutations (G174_TAA-CAA, T330_GAC-AAC) from the reference gene accessed as GenBank no. KC534862.1, but there were no amino acid sequence variations.
The gene acrR in the transcriptional repressor operon of the multidrug efflux transporter was found to be closely linked with either acrEF (Fig. 2A) or acrAB (Fig. 2B). The acrR gene linked with acrAB was found to have 31 base pairs mutated at 3 regions in the amino acid sequence (F115Y, I116V and P216S) from previously accessed K. pneumoniae acrR (GenBank no. CP065838.1). The acrR gene linked with acrEF was identical to the previously accessed acrEF/envCD operon transcriptional regulator product domain (GenBank no. CP034540.1). The gene structure areas around these operons are presented in Fig. 2.
The multidrug efflux RND transporter periplasmic adaptor subunit oqxA and permease subunit region oqxB were also discovered on the chromosome, which is known as oqxAB in a combined form (Fig. 3). The regional gene structure around oqxAB was identical in both strains, as mapped in Fig. 3. Additionally, novel mutation sites were discovered in both the oqxA and oqxB genes that were not previously identified. The multidrug efflux RND transporter periplasmic adaptor subunit oqxA was found to have 2 base pair mutations (comparative gene GenBank accession no. CP098169.1) but no amino acid sequence substitutions. Moreover, the multidrug efflux RND transporter permease subunit oqxB was found with 12 mutation sites and a substitution of M881V compared to the NCBI reference gene oqxB26.
The DNA gyrase subunit gyrA was identified in the chromosome, with 82-point mutation sites and 4 amino acid sequence variations (comparative gene GenBank no. CP065838.1). This type of mutation has never been reported or identified before. A previously unreported variation was also identified from the DNA topoisomerase IV subunit parC, with a mutated amino acid site of S81I. These types of mutations can confer additional resistance against antimicrobial classes of fluoroquinolone.
A new variation in the resistance gene fosA, which can confer resistance against Fosfomycin, was also discovered on the chromosome, with 96.7% identity compared to published data. The genetic sequence of mutated fosA in both strains was identical.
Identified plasmids from the CPKP isolates
Multiple plasmids encoding various antimicrobial resistance genes were identified from both CPKP strains. Four plasmids were assembled from both strains, ranging from 46–465 kbp (Fig. 4A-D). Plasmid types of IncHI1B (pNDM-MAR), IncFIB (K), IncFIB (pNDM-Mar), IncR, IncFII and IncX3 were identified from both strains. All plasmids were found to contain antibiotic resistance β-lactamase genes, including the carbapenemase blaNDM-5 carried by the IncX3 plasmid. Two sites of ESBL encoding blaTEM-1B gene were discovered from two different plasmids, IncR and IncFII.
The plasmid pKP1-IncHIB/IncFIB (Fig. 4A) was sequenced and assembled with 529 CDS encoding sites and 48.04% GC content (Table 1). Three plasmid types were identified in the pKP1-IncHIB/IncFIB, namely IncFIB(pNDM-Mar), IncHI1B(pNDM-MAR) and IncFIB(K). The pKP4-IncHIB/IncFIB, identified from DMCPKP4 was assembled 22,080 base-pair shorter than pKP1-IncHIB/IncFIB. Various AMR genes were identified from this plasmid, which would confer multidrug resistance (MDR) with the plasmid alone. The contributable antimicrobial agents from this plasmid included: aminoglycosides (aadA16, aac(6’)lb-cr, armA and aph(3’)-la), tetracyclines (tet(B)), macrolides (mphA, mphE and msrE), quinolones (aac(6’)lb-cr and qnrB4), folate pathway antagonists (sul1 and dfrA27), rifamycins (arr-3), aminocyclitols (aadA16) and β-lactams (blaDHA-1 and blaSHV-12). The plasmid carried by DMCPKP1 (pKP1-IncHIB/IncFIB) was found with additional resistance genes of qnrB4, blaDHA-1, armA, msrE and mphE.
The IncR type plasmid pKP1-gtc3L95 was sequenced and was as long as 95,047 bp with 111 CDS encoding sites and 52.4% of GC content, whereas pKP4-gtc3L95 was a single base pair shorter with 107 CDS encoding sites (Fig. 4B). The plasmid encoded multiple resistance genes, including extended-spectrum β-lactamase (ESBL) which could be enough to confer MDR capability to the organism. The AMR genes carried by the IncR plasmid were able to contribute to resistance against various classes of drugs, such as aminoglycosides (aph(6)-Id and aac(3)-IId), phenicols (floR), sulphonamides (sul1), tetracyclines (tet(A) and tetR), trimethoprims (dfrA12) and β-lactams (blaCTX-M-14 and blaTEM-1B). Notably, a gene structure carrying multiple AMR genes coupled with MGEs was identified; IS1663-blaTEM-1B-tnpR-Tn2-tet(A)-tetR-aph(6)Id-IS26-aac(3)IId-ISVsa5-ISVsa5- blaCTX-M-14-IS903.
pKP1-gtc5L70 was sequenced and identified as a 70,930 base pair long plasmid (Fig. 4C), featuring 51.05% GC content and containing 84 CDS encoding sites. An identical plasmid, pKP4-gtc4L70, was identified from DMCPKP4, featuring sequences as long as 70,932 base pairs with 84 CDS encoding sites. Both plasmids were typed as incompatibility type IncFII. The IncFII plasmids contained broad-spectrum class A β-lactamase encoding gene blaTEM-1B and quinolone resistance pentapeptide repeat protein qnrS1. The ESBL-encoding gene blaTEM-1B was found with a variation, with 99.77% identity from that of the reference accession gene no. AY458016.
The IncX3 plasmids pKP1-NDM5 and pKP4-NDM5, which were characterized in the previous study , were also reidentified as a result of the sequencing and assembly (Fig. 4D). The plasmids were identified as long as 46,112 base pairs long with 122 CDS encoding regions, carrying the subclass B1 metallo-β-lactamase NDM-5 encoding blaNDM-5 gene.
The genome sequences of the chromosome and plasmids of DMCPKP1 and DMCPKP4 have been deposited in NCBI GenBank under BioProject accession number PRJNA858561.
Bioinformatic resistance gene distribution comparison with whole genome phylogeny
Epidemiological analysis was conducted using previously described K. pneumoniae whole-genome datasets accessible from GenBank (Supplementary Table S3). A total of 67 strains of accessible whole-genome datasets from GenBank, including K. pneumoniae HS11286 (GenBank no. CP003200.1), were identified and compared with 2 datasets from this study. As a result of characteristic gene identification, a total of 114 AMR genes (Supplementary Table S4) and 27 types of plasmids (Supplementary Table S5) were discovered from the K. pneumoniae datasets. Among resistance genes, the aminoglycoside acetyltransferase aac(6')-Ib-cr gene was carried by 28 strains in this study, which is known for conferring ciprofloxacin resistance . The aminoglycoside phosphotransferase aph(3'')-Ib was carried by 20 strains of K. pneumoniae, and 50% of the genes were identified as a modified form. Among β-lactamases, blaTEM-1B and blaSHV-182 were found in 24 and 21 K. pneumoniae strains, respectively. The blaKPC-2 and blaNDM-1, known as carbapenemase genes, were also identified in 18 and 13 strains, respectively. The blaNDM-5-harboring ST378 K. pneumoniae strains carried aac(6')-Ib-cr and blaTEM-1B, but did not carry aph(3'')-Ib, blaSHV-182, blaKPC-2 or blaNDM-1. Plasmids were identified from 50 whole-genome datasets from GenBank. Among the plasmids, IncFIB(K) and IncR were the most frequently discovered types. These plasmids were also found in ST378 K. pneumoniae strains.
The identified pairwise whole-chromosome SNP difference (Supplementary Table S6) between the datasets ranged from 0 to 17,719. The smallest SNP difference (0 point) was found between strain DMCPKP1 and DMCPKP4 from this study, followed by a 2-point difference identified between strains C2601 (GenBank no. CP039813.1) and C2972 (GenBank no. CP039802.1). The ST378 strains were identified to have SNP differences ranging from 15,651 to 17,139 compared to other strains, indicating their phylogenetic distance from other K. pneumoniae datasets. The ML phylogenetic tree was constructed using the whole-chromosome SNPs, and visualized with the characterized AMR genes and plasmid types in Fig. 5.
Epidemiological profiles of 69 K. pneumoniae strains were presented along with the phylogenetic tree (Fig. 6). Isolated country, isolation year and MLST data are displayed with distinguishable colors and strips. The identified K. pneumoniae strains from 14 different countries and 32 different MLST types were visualized. A total of 16 whole-genome datasets from the USA and China were included in the study, which were the countries with the highest inclusion, followed by 13 datasets reported from Italy. The most frequently included MLST types in the analysis were ST11 and ST258. The whole-genome phylogenetic tree displayed the distance of the ST378 strains from other datasets, confirming that the isolates constitute a novel type of CPKP.
The AMR genes identified through whole-genome analysis of ST378 K. pneumoniae are well known for contributing to MDR capability against various classes of antimicrobial agents. High resistance levels against various classes of antimicrobial agents were confirmed (Supplementary Table S2) in the MIC level measurements conducted in a previous study . One of the aims of the whole-genome analysis conducted this study was to identify the genomic origin contributing to the broad spectrum of AMR capability of ST378 isolates. In the whole-genome analysis, AMR genes contributable against various classes of antimicrobial agents were identified, namely aminoglycosides (armA, aac(6’)-lb-cr, aac(3)-lld), aminocyclitols (aadA16 and aadA2), β-lactams (blaNDM-5, blaSHV-12, blaSHV-119, blaDHA-1, blaTEM-1B and blaCTX-M-14), folate pathway antagonists (sul1, oqxA, oqxB, dfrA12, dfrA27), fosfomycins (fosA), macrolides (mph(A) and msr(E)), quinolones (aac(6’)-lb-cr, acrR, qnrB4, qnrS1, gyrA and parC), rifamycin (ARR-3), streptogramin B (msr(E)) and tetracyclines (tet(A) and tet(B)). The confirmed MIC levels of ST378 strains were explainable with the results of the whole-genome identification, against aminoglycosides, β-lactams, fluoroquinolones, quinolones and tetracyclines. Only a limited number of antimicrobial agents, colistin and polymyxin B, remained as valuable options. However, the level of colistin resistance in K. pneumoniae is  rising rapidly worldwide. Therefore, additional control measures to address the emergence and spread of colistin-resistant CPKP must be taken seriously for the sake of public health.
Novel base pair substitution sites of the efflux pump genes oqxA and oqxB were identified in this study. While oqxA was found without any amino acid substitutions compared to a previously accessed sequence, oqxB showed 12-point mutations, resulting in a single substitution in the amino acid sequence from oqxB26. The genetic structure around the oqxAB gene was comparable to that of the K. pneumoniae strains accessed in previous studies [34, 35], with 99.35% identity and 100% query coverage, as revealed by a BLAST search. The OqxAB efflux pump is known to contribute to resistance against quinolones, tigecycline, and nitrofurantoin . The phenotypic results of these strains showed corresponding resistance against quinolones but without tigecycline resistance, and nitrofurantoin resistance was not tested . The chromosome-based efflux membrane transporter OqxAB was suggested to originate from K. pneumoniae, with a higher prevalence in Klebsiella spp. and Enterobacter spp. . In South Korea, OqxAB was detected and reported from K. pneumoniae blood culture isolates collected between 2005 and 2010, but it was not detected in Escherichia coli isolates . The work of Chen et al. in 2015 warned that the OqxAB operon could be mobilized via transposition events on mobile genetic elements, leading to the overexpression of efflux pumps . Therefore, possible future synergism of oqxAB genes with MGEs such as plasmids and transposons must be considered and closely monitored.
In addtion, multiple variations in AMR gene sites, such as ompK36, ompK37, acrR, gyrA and parC, were revealed in this analysis. The functional differences of these varied gene products, such as OmpK36, are difficult to evaluate independently. However, mutation of the outer membrane porin at one or more gene sites is known to increase carbapenem resistance [40, 41]. The porin protein OmpK37 was suggested to have a narrower pore channel than OmpK36 and OmpK35, resulting in decreased susceptibility to β-lactam antibiotics . In K. pneumoniae, deletion or alteration of outer membrane proteins is known to contribute to carbapenem resistance, especially when associated with ESBL or AmpC enzyme production [43, 44]. AcrR is known to bind to the promoter region of acrA/acrR and function as a negative modulator of the acrAB transcription level, leading to a decrease in the overexpression of acrAB [45, 46]. In other words, exclusion of acrR led to the upregulation of acrAB transcription . Mutation of the repressor acrR was reported to have an effect on overexpression of acrA and acrB [47, 48]. Three amino acid sequence mutation sites were discovered in this sequencing of the acrRAB gene, which could result in the modification of the repressive function of acrR and overexpression of acrAB. Furthermore, the novel mutation sites were identified in the DNA topoisomerase-encoding sequence, with four regions in gyrA and one region in parC, which could lead to increased resistance through mutated drug target sites of fluoroquinolone agents. Therefore, the identified resistance mechanisms coupled in the ST378 CPKP strains must be monitored not only in human isolates but also in the animal isolates.
The whole-genome phylogenetic tree was constructed to measure the phylogenetic distance of ST378 K. pneumoniae strains from previously described isolates. Among the datasets, KPNIH48 (GenBank no. CP026392.1) was found to be phylogenetically close to the ST378 strains, which were isolated from the USA and typed as ST252. Similar resistance gene prevalence patterns were observable among closely related strains. However, the prevalence patterns of resistance genes and plasmid types were different for ST378 compared to neighboring strains. The ST378 K. pneumoniae has never been reported as a CPKP before. The identification of its genetic structure and gene distribution comparison using a whole-genome approach has revealed speculative coupling of multiple mechanisms contributing to resistance against various classes of antimicrobial agents. The epidemiologic analysis using a whole-genome approach in this study reveals the emergence of a novel strain of CPKP.
It is noteworthy that both ST378 strains have four heterogeneous plasmids (Fig. 4), and each plasmid harbors different resistance genes, instead of a single plasmid carrying multiple AMR genes. In the ST378 K. pneumoniae, the chromosome and three plasmids (Fig. 4A-C) were each identified to carry their own ESBL genes. The other plasmid was found to carry a carbapenemase gene. The characteristics of the plasmids carried by ST378 strains may indicate the process through which the ST378 strains have acquired MDR genes. Additionally, as reported in other K. pneumoniae strains, including the strains in this study, ST378 strains are expected to acquire further MGEs suitable for their survival.
In this study, two identified strains were analyzed due to the limited number of discovered isolates. The CPE surveillance system is not designed to adequately consider companion animals, even though they are closely associated with human society. Therefore, even if our study is not enough to represent our society, the genomic findings from these isolates should be considered seriously, because the subjects of this study are the first identified CPKP from companion animals in Korea. Both strains were identified from urine samples of dogs in Korea, which were suffering from urinary tract infections. The emergence of a novel CPKP strain, carrying various AMR genes coupled with MGEs, from a companion dog shows that CPKP poses a threat not limited to human health in our society. Considering the serious findings in this study, the unauthorized usage of carbapenems in veterinary clinics should be regarded as a serious concern.
The whole-genome analysis of this study reveals the emergence of a novel strain of CPKP. The CPKP isolates in this study are characterized by their high resistance levels against various antimicrobial agents and their carriage of various AMR genes. Considering that the isolates are identified from companion animals, future control measures should be taken seriously from a "One Health approach" perspective.
Availability of data and materials
All referred sequences of this study are available from the NCBI BioProject number PRJNA858561. All data generated or analyzed during this study have been submitted with this manuscript. All genetic information of the plasmids was deposited in GenBank. Therefore, all data from this study are available on public.
Carbapenemase -producing Enterobacterales
Carbapenemase-producing K. pneumoniae
Interactive tree of life
Minimum inhibitory concentration
Mobile gene elements
Multi-locus sequence typing
Bengoechea JA, Sa Pessoa J. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev. 2019;43(2):123–44.
Zammit SC, Azzopardi N, Sant J. Mortality risk score for Klebsiella pneumoniae bacteraemia. Eur J Intern Med. 2014;25(6):571–6.
Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999–2005). Diagn Microbiol Infect Dis. 2006;56(4):367–72.
Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–106.
Akova M, Daikos G, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439–48.
Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2–producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364–73.
Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791.
Suay-García B, Pérez-Gracia M. Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics (Basel). 2019;8(3):122.
Haidar G, Clancy CJ, Chen L, Samanta P, Shields RK, Kreiswirth BN, Nguyen MH. Identifying spectra of activity and therapeutic niches for ceftazidime-avibactam and imipenem-relebactam against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2017;61(9):e00642–e617.
Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(suppl_1):S28–36.
Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2017;6(1):1.
Yoon E-J, Yang JW, Kim JO, Lee H, Lee KJ, Jeong SH. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the national laboratory surveillance system. Future Microbiol. 2018;13(07):771–83.
Kyung SM, Choi S-W, Lim J, Shim S, Kim S, Im YB, Lee N-E, Hwang C-Y, Kim D, Yoo HS. Comparative genomic analysis of plasmids encoding metallo-β-lactamase NDM-5 in Enterobacterales Korean isolates from companion dogs. Sci Rep. 2022;12(1):1–9.
Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. 2019;37(5):540–6.
Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595.
Hunt M, Silva ND, Otto TD, Parkhill J, Keane JA, Harris SR. Circlator: automated circularization of genome assemblies using long sequencing reads. Genome Biol. 2015;16(1):1–10.
Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, Cuomo CA, Zeng Q, Wortman J, Young SK. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS ONE. 2014;9(11):e112963.
Simão FA, Waterhouse RM, Ioannidis P, Kriventseva EV, Zdobnov EM. BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs. Bioinformatics. 2015;31(19):3210–2.
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9.
Buchfink B, Reuter K, Drost H-G. Sensitive protein alignments at tree-of-life scale using DIAMOND. Nat Methods. 2021;18(4):366–8.
Dimmer EC, Huntley RP, Alam-Faruque Y, Sawford T, O’Donovan C, Martin MJ, Bely B, Browne P, Mun Chan W, Eberhardt R. The UniProt-GO annotation database in 2011. Nucleic Acids Res. 2012;40(D1):D565–70.
Conesa A, Götz S, García-Gómez JM, Terol J, Talón M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics. 2005;21(18):3674–6.
Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4.
Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, Møller Aarestrup F, Hasman H. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–903.
Johansson MH, Bortolaia V, Tansirichaiya S, Aarestrup FM, Roberts AP, Petersen TN. Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder. J Antimicrob Chemother. 2021;76(1):101–9.
Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764–8.
Couvin D, Bernheim A, Toffano-Nioche C, Touchon M, Michalik J, Néron B, Rocha EP, Vergnaud G, Gautheret D, Pourcel C. CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res. 2018;46(W1):W246–51.
Stothard P, Wishart DS. Circular genome visualization and exploration using CGView. Bioinformatics. 2005;21(4):537–9.
Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS ONE. 2014;9(8):e104984.
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547.
Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50(4):1355–61.
Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac (6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953–5.
Ah Y-M, Kim A-J, Lee J-Y. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents. 2014;44(1):8–15.
Yoon E-J, Gwon B, Liu C, Kim D, Won D, Park SG, Choi JR, Jeong SH. Beneficial chromosomal integration of the genes for CTX-M extended-spectrum β-lactamase in Klebsiella pneumoniae for stable propagation. Msystems. 2020;5(5):e00459–e420.
Gorrie CL, Mirceta M, Wick RR, Judd LM, Wyres KL, Thomson NR, Strugnell RA, Pratt NF, Garlick JS, Watson KM. Antimicrobial-resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital. Clin Infect Dis. 2018;67(2):161–70.
Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8(1):1–13.
Hansen LH, Sørensen SJ, Jørgensen HS, Jensen LB. The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs. Microb Drug Resist. 2005;11(4):378–82.
Yang HY, Nam YS, Lee HJ. Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea. Can J Infect Dis Med Microbiol. 2014;25(3):163–9.
Wong MHY, Chan EWC, Chen S. Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother. 2015;59(6):3290–7.
Wise MG, Horvath E, Young K, Sahm DF, Kazmierczak KM. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. J Med Microbiol. 2018;67(3):289–95.
Rocker A, Lacey JA, Belousoff MJ, Wilksch JJ, Strugnell RA, Davies MR, Lithgow T. Global trends in proteome remodeling of the outer membrane modulate antimicrobial permeability in Klebsiella pneumoniae. MBio. 2020;11(2):e00603–00620.
Doménech-Sánchez A, Hernández-Allés S, Martínez-Martínez L, Benedí VJ, Albertí S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in β-lactam antibiotic resistance. J Bacteriol Res. 1999;181(9):2726–32.
Martínez-Martínez L. Extended-spectrum β-lactamases and the permeability barrier. Clin Microbiol Infect. 2008;14:82–9.
Hamzaoui Z, Ocampo-Sosa A, Martinez MF, Landolsi S, Ferjani S, Maamar E, Saidani M, Slim A, Martinez-Martinez L. Boubaker IB-B: Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2018;52(6):898–905.
Su C-C, Rutherford DJ, Edward WY. Characterization of the multidrug efflux regulator AcrR from Escherichia coli. Biochem Biophys Res Commun. 2007;361(1):85–90.
Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol. 1996;19(1):101–12.
Webber MA, Piddock LJ. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother. 2001;45(5):1550–2.
Wang H, Dzink-Fox JL, Chen M, Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother. 2001;45(5):1515–21.
The authors have no conflicts of interest to declare.
This work was supported by the National Research Foundation (NRF- 2020R1A2C200879414), National Institute of Wildlife Disease Control and Prevention as “Specialized Graduate School Support Project for Wildlife Disease Specialists”, BK21 FOUR Future Veterinary Medicine Leading Education and Research Center and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
Ethics approval and consent to participate
Consent for publication
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The whole genome profiles of sequenced K. pneumoniae isolates. Table S2. Previously tested MIC profiles of the DMCPKP1 and DMCPKP4. Table S2. Previously tested MIC profiles of the DMCPKP1 and DMCPKP4. Table S4. Gene identities of the antimicrobial resistance genes discovered from the whole-genome of 69 K. pneumoniae datasets. Table S4. Gene identities of the antimicrobial resistance genes discovered from the whole-genome of 69 K. pneumoniae datasets. Table S6. The pairwise SNP difference matrix of whole chromosome datasets extracted from the reference genome.
About this article
Cite this article
Kyung, S.M., Lee, J.H., Lee, ES. et al. Whole genome structure and resistance genes in carbapenemase-producing multidrug resistant ST378 Klebsiella pneumoniae. BMC Microbiol 23, 323 (2023). https://doi.org/10.1186/s12866-023-03074-7